Redistribution of CB1 Cannabinoid Receptors in the Acute and Chronic Phases of Pilocarpine-Induced Epilepsy

The endocannabinoid system plays a central role in retrograde synaptic communication and may control the spread of activity in an epileptic network. Using the pilocarpine model of temporal lobe epilepsy we examined the expression pattern of the Type 1 cannabinoid receptor (CB1-R) in the hippocampi of CD1 mice at survival times of 2 hours, 1 day, 3 days and 2 months (acute, latent and chronic phases). Based on the behavioral signs of the acute seizures, animals were classified as “weakly” or “strongly” epileptic using the modified Racine scale. Mice of the weak group had mild seizures, whereas seizures in the strong group were frequent with intense motor symptoms and the majority of these animals developed sclerosis in the chronic phase. In control samples the most intense staining of CB1-R-positive fibers was found in the molecular layer of the dentate gyrus and in str. pyramidale of the cornu Ammonis. In weak animals no significant changes were seen at any survival time compared to controls. In strong animals, however, in the acute phase, a massive reduction in CB1-R-stained terminals occurred in the hippocampus. In the latent phase CB1-R immunoreactivity gradually recovered. In the chronic phase, CB1-immunostaining in sclerotic samples was stronger throughout the hippocampus. Quantitative electron microscopic analysis showed an increase in the number of CB1-R-positive terminals in the dentate gyrus. Moreover, the number of immunogold particles significantly increased in GABAergic terminals. Our results suggest a proconvulsive downregulation of CB1 receptors in the acute phase most probably due to receptor internalization, followed by compensatory upregulation and sprouting in the chronic phase of epilepsy. In conclusion, the changes in CB1 receptor expression pattern revealed in this study are associated with the severity of hippocampal injury initiated by acute seizures that ultimately leads to sclerosis in the vulnerable regions in the chronic phase.

[1]  Koen Van Laere,et al.  In vivo activation of endocannabinoid system in temporal lobe epilepsy with hippocampal sclerosis. , 2011, Brain : a journal of neurology.

[2]  Christophe Mulle,et al.  Pharmacological Activation of Kainate Receptors Drives Endocannabinoid Mobilization , 2011, The Journal of Neuroscience.

[3]  M. Klugmann,et al.  AAV Vector-Mediated Overexpression of CB1 Cannabinoid Receptor in Pyramidal Neurons of the Hippocampus Protects against Seizure-Induced Excitoxicity , 2010, PloS one.

[4]  T. Freund,et al.  Loss and reorganization of calretinin-containing interneurons in the epileptic human hippocampus. , 2010, Brain : a journal of neurology.

[5]  Peter T. Nguyen,et al.  Chronic monoacylglycerol lipase blockade causes functional antagonism of the endocannabinoid system , 2010, Nature Neuroscience.

[6]  T. Freund,et al.  Dynamic changes of CB1‐receptor expression in hippocampi of epileptic mice and humans , 2010, Epilepsia.

[7]  I. Módy,et al.  Selective Reduction of Cholecystokinin-Positive Basket Cell Innervation in a Model of Temporal Lobe Epilepsy , 2010, The Journal of Neuroscience.

[8]  Bret N. Smith,et al.  Cannabinoid-Mediated Inhibition of Recurrent Excitatory Circuitry in the Dentate Gyrus in a Mouse Model of Temporal Lobe Epilepsy , 2010, PloS one.

[9]  Julio C. Echegoyen,et al.  Single application of a CB1 receptor antagonist rapidly following head injury prevents long-term hyperexcitability in a rat model , 2009, Epilepsy Research.

[10]  Kevan A. C. Martin,et al.  A systematic random sampling scheme optimized to detect the proportion of rare synapses in the neuropil , 2009, Journal of Neuroscience Methods.

[11]  B. Martin,et al.  Temporal characterization of changes in hippocampal cannabinoid CB1 receptor expression following pilocarpine-induced status epilepticus , 2009, Brain Research.

[12]  István Katona,et al.  Endocannabinoid signaling as a synaptic circuit breaker in neurological disease , 2008, Nature Medicine.

[13]  K. Mackie.  Signaling via CNS cannabinoid receptors , 2008, Molecular and Cellular Endocrinology.

[14]  Masahiko Watanabe,et al.  Downregulation of the CB1 Cannabinoid Receptor and Related Molecular Elements of the Endocannabinoid System in Epileptic Human Hippocampus , 2008, The Journal of Neuroscience.

[15]  D. Piomelli,et al.  A neuroscientist's guide to lipidomics , 2007, Nature Reviews Neuroscience.

[16]  R. E. Blair,et al.  Status epilepticus causes a long-lasting redistribution of hippocampal cannabinoid type 1 receptor expression and function in the rat pilocarpine model of acquired epilepsy , 2007, Neuroscience.

[17]  T. Kuner,et al.  A Molecular Basis of Analgesic Tolerance to Cannabinoids , 2007, The Journal of Neuroscience.

[18]  T. Freund,et al.  Correlated species differences in the effects of cannabinoid ligands on anxiety and on GABAergic and glutamatergic synaptic transmission , 2007, The European journal of neuroscience.

[19]  G. Buzsáki,et al.  Morphology and synaptic input of substance P receptor-immunoreactive interneurons in control and epileptic human hippocampus , 2007, Neuroscience.

[20]  Ivan Soltesz,et al.  Prevention of Plasticity of Endocannabinoid Signaling Inhibits Persistent Limbic Hyperexcitability Caused by Developmental Seizures , 2007, The Journal of Neuroscience.

[21]  Beat Lutz,et al.  The Endocannabinoid System Controls Key Epileptogenic Circuits in the Hippocampus , 2006, Neuron.

[22]  T. Freund,et al.  Molecular Composition of the Endocannabinoid System at Glutamatergic Synapses , 2006, The Journal of Neuroscience.

[23]  K. Mackie,et al.  Cannabinoid receptors and endocannabinoids: Evidence for new players , 2006, The AAPS Journal.

[24]  K. Mackie,et al.  Cannabinoid receptors and endocannabinoids , 2006 .

[25]  G. Tamás,et al.  Excitatory Effect of GABAergic Axo-Axonic Cells in Cortical Microcircuits , 2006, Science.

[26]  T. Freund,et al.  CB1 cannabinoid receptors are enriched in the perisynaptic annulus and on preterminal segments of hippocampal GABAergic axons , 2005, Neuroscience.

[27]  C. Houser,et al.  Temporal Patterns of Fos Expression in the Dentate Gyrus after Spontaneous Seizures in a Mouse Model of Temporal Lobe Epilepsy , 2005, The Journal of Neuroscience.

[28]  T. Freund,et al.  Impaired and repaired inhibitory circuits in the epileptic human hippocampus , 2005, Trends in Neurosciences.

[29]  Y. Ben-Ari,et al.  Multiple facets of GABAergic neurons and synapses: multiple fates of GABA signalling in epilepsies , 2005, Trends in Neurosciences.

[30]  T. Freund,et al.  Surviving CA1 pyramidal cells receive intact perisomatic inhibitory input in the human epileptic hippocampus. , 2004, Brain : a journal of neurology.

[31]  B. Lutz.  On-demand activation of the endocannabinoid system in the control of neuronal excitability and epileptiform seizures. , 2004, Biochemical pharmacology.

[32]  Masahiko Watanabe,et al.  Two distinct classes of muscarinic action on hippocampal inhibitory synapses: M2‐mediated direct suppression and M1/M3‐mediated indirect suppression through endocannabinoid signalling , 2004, The European journal of neuroscience.

[33]  M. Eder,et al.  CB1 Cannabinoid Receptors and On-Demand Defense Against Excitotoxicity , 2003, Science.

[34]  B. Martin,et al.  The Endogenous Cannabinoid System Regulates Seizure Frequency and Duration in a Model of Temporal Lobe Epilepsy , 2003, Journal of Pharmacology and Experimental Therapeutics.

[35]  M. Poo,et al.  Coincident Pre- and Postsynaptic Activity Modifies GABAergic Synapses by Postsynaptic Changes in Cl− Transporter Activity , 2003, Neuron.

[36]  T. Freund,et al.  Long-Term Plasticity of Endocannabinoid Signaling Induced by Developmental Febrile Seizures , 2003, Neuron.

[37]  T. Freund,et al.  Role of endogenous cannabinoids in synaptic signaling. , 2003, Physiological reviews.

[38]  Y. Isomura,et al.  Excitatory gaba input directly drives seizure-like rhythmic synchronization in mature hippocampal CA1 pyramidal cells , 2003, Neuroscience.

[39]  T. Freund,et al.  Excitement Reduces Inhibition via Endocannabinoids , 2003, Neuron.

[40]  R. Nicoll,et al.  GABA Generates Excitement , 2003, Neuron.

[41]  W. Couldwell.  Cohen I, Navarro V, Clemenceau S, Baulac M, Miles R:On the origin of interictal activity in human temporal lobe epilepsy in vitro. Science 298:1418–1421, 2002 , 2003 .

[42]  L. Wittner,et al.  Synaptic reorganization of calbindin-positive neurons in the human hippocampal CA1 region in temporal lobe epilepsy , 2002, Neuroscience.

[43]  R. Miles,et al.  On the Origin of Interictal Activity in Human Temporal Lobe Epilepsy in Vitro , 2002, Science.

[44]  J. Sullivan,et al.  Cannabinoid receptors , 2002, Current Biology.

[45]  M. Kano,et al.  Presynaptic Cannabinoid Sensitivity Is a Major Determinant of Depolarization-Induced Retrograde Suppression at Hippocampal Synapses , 2002, The Journal of Neuroscience.

[46]  R. Nicoll,et al.  Endocannabinoid Signaling in the Brain , 2002, Science.

[47]  Z. Borhegyi,et al.  Preservation of perisomatic inhibitory input of granule cells in the epileptic human dentate gyrus , 2001, Neuroscience.

[48]  B. Alger,et al.  Metabotropic Glutamate Receptors Drive the Endocannabinoid System in Hippocampus , 2001, The Journal of Neuroscience.

[49]  L. Devi,et al.  G-protein-coupled receptor dimerization: modulation of receptor function. , 2001, Pharmacology & therapeutics.

[50]  O. Devinsky,et al.  Alcohol and Marijuana: Effects on Epilepsy and Use by Patients with Epilepsy , 2001, Epilepsia.

[51]  T. Freund,et al.  Novel cannabinoid-sensitive receptor mediates inhibition of glutamatergic synaptic transmission in the hippocampus , 2001, Neuroscience.

[52]  Lakshmi A. Devi,et al.  G protein coupled receptor dimerization: implications in modulating receptor function , 2001, Journal of Molecular Medicine.

[53]  G. Vachtsevanos,et al.  Epileptic Seizures May Begin Hours in Advance of Clinical Onset A Report of Five Patients , 2001, Neuron.

[54]  Sharon Anavi-Goffer,et al.  Agonist-Induced Internalization and Trafficking of Cannabinoid CB1 Receptors in Hippocampal Neurons , 2001, The Journal of Neuroscience.

[55]  I. Módy,et al.  Cannabinoids inhibit hippocampal GABAergic transmission and network oscillations , 2000, The European journal of neuroscience.

[56]  J. Sullivan,et al.  Mechanisms of cannabinoid-receptor-mediated inhibition of synaptic transmission in cultured hippocampal pyramidal neurons. , 1999, Journal of neurophysiology.

[57]  J. Sullivan,et al.  Mechanism of Cannabinoid Effects on Long-Term Potentiation and Depression in Hippocampal CA1 Neurons , 1999, The Journal of Neuroscience.

[58]  K. Mackie,et al.  Internalization and Recycling of the CB1 Cannabinoid Receptor , 1999, Journal of neurochemistry.

[59]  J. McNamara.  Emerging insights into the genesis of epilepsy , 1999, Nature.

[60]  M. Kathmann,et al.  Cannabinoid CB1 receptor-mediated inhibition of NMDA- and kainate-stimulated noradrenaline and dopamine release in the brain , 1999, Naunyn-Schmiedeberg's Archives of Pharmacology.

[61]  Ken Mackie,et al.  Presynaptically Located CB1 Cannabinoid Receptors Regulate GABA Release from Axon Terminals of Specific Hippocampal Interneurons , 1999, The Journal of Neuroscience.

[62]  L. Acsády,et al.  Postsynaptic targets of somatostatin-immunoreactive interneurons in the rat hippocampus , 1999, Neuroscience.

[63]  M. Parmentier,et al.  Unresponsiveness to cannabinoids and reduced addictive effects of opiates in CB1 receptor knockout mice. , 1999, Science.

[64]  Peter Somogyi,et al.  Increased number of synaptic GABAA receptors underlies potentiation at hippocampal inhibitory synapses , 1998, Nature.

[65]  T. Freund,et al.  Loss of Calbindin-D28K immunoreactivity from dentate granule cells in human temporal lobe epilepsy , 1997, Neuroscience.

[66]  J. Engel.  Excitation and Inhibition in Epilepsy , 1996, Canadian Journal of Neurological Sciences / Journal Canadien des Sciences Neurologiques.

[67]  A. N. van den Pol,et al.  Excitatory Actions of GABA after Neuronal Trauma , 1996, The Journal of Neuroscience.

[68]  L. Venance,et al.  Biosynthesis of an Endogenous Cannabinoid Precursor in Neurons and its Control by Calcium and cAMP , 1996, The Journal of Neuroscience.

[69]  T. Freund,et al.  Delayed cell death in the contralateral hippocampus following kainate injection into the CA3 subfield , 1995, Neuroscience.

[70]  P. Gass,et al.  Correlation between seizure intensity and stress protein expression after limbic epilepsy in the rat brain , 1995, Neuroscience.

[71]  E. Cavalheiro,et al.  Effects of conventional antiepileptic drugs in a model of spontaneous recurrent seizures in rats , 1995, Epilepsy Research.

[72]  A. Obenaus,et al.  Loss of glutamate decarboxylase mRNA-containing neurons in the rat dentate gyrus following pilocarpine-induced seizures , 1993, The Journal of neuroscience : the official journal of the Society for Neuroscience.

[73]  T. Freund,et al.  Selective neuronal death in the contralateral hippocampus following unilateral kainate injections into the CA3 subfield , 1993, Neuroscience.

[74]  Orrin Devinsky,et al.  Epilepsy and Behavior , 1991 .

[75]  C. Houser.  Granule cell dispersion in the dentate gyrus of humans with temporal lobe epilepsy , 1990, Brain Research.

[76]  D. Lowenstein,et al.  The pattern of 72-kDa heat shock protein-like immunoreactivity in the rat brain following flurothyl-induced status epilepticus , 1990, Brain Research.

[77]  G. Cascino,et al.  Mossy fiber synaptic reorganization in the epileptic human temporal lobe , 1989, Annals of neurology.

[78]  Pl Lantos,et al.  Greenfield's Neuropathology , 1985 .

[79]  Z. Bortolotto,et al.  Seizures produced by pilocarpine in mice: A behavioral, electroencephalographic and morphological analysis , 1984, Brain Research.

[80]  E. Carlini,et al.  Chronic administration of cannabidiol to healthy volunteers and epileptic patients. , 1980, Pharmacology.

[81]  Carl W. Cotman,et al.  Selective reinnervation of hippocampal area CA1 and the fascia dentata after destruction of CA3-CA4 afferents with kainic acid , 1980, Brain Research.

[82]  D. Nair,et al.  Epilepsy , 1977, Journal of Neurology.

[83]  R. Racine,et al.  Modification of seizure activity by electrical stimulation. II. Motor seizure. , 1972, Electroencephalography and clinical neurophysiology.

[84]  Keeler Mh,et al.  Grand mal convulsions subsequent to marijuana use. Case report. , 1967 .

[85]  Masahiko Watanabe,et al.  Endocannabinoid-mediated control of synaptic transmission. , 2009, Physiological reviews.

[86]  K. Mackie,et al.  Distribution of cannabinoid receptors in the central and peripheral nervous system. , 2005, Handbook of experimental pharmacology.

[87]  M. Abood.  Molecular biology of cannabinoid receptors. , 2005, Handbook of experimental pharmacology.

[88]  T. Freund,et al.  Immunocytochemically defined interneuron populations in the hippocampus of mouse strains used in transgenic technology , 2004, Hippocampus.

[89]  Y. Ben-Ari,et al.  Dendritic but not somatic GABAergic inhibition is decreased in experimental epilepsy , 2001, Nature Neuroscience.

[90]  R. Green.  Neuropathology and behavior in epilepsy , 1991 .

[91]  J. Wolff,et al.  A reliable and sensitive method to localize terminal degeneration and lysosomes in the central nervous system. , 1980, Stain technology.

[92]  M. Keeler,et al.  Grand mal convulsions subsequent to marijuana use. Case report. , 1967, Diseases of the nervous system.

[93]  M. Keeler,et al.  Grand mal convulsions subsequent to marijuana use. , 1967 .